Background: Alzheimer's disease (AD) commonly accompanies cerebral amyloid
angiopathy (CAA). Objective: We aimed to reveal associations between CAA-related brain …

Dementia is a multifactorial disorder that is likely influenced by both Alzheimer's disease
(AD) and vascular pathologies. We evaluated domain-specific cognitive and …

We investigated whether subtypes of Alzheimer's disease (AD), that is, typical, limbic-
predominant, hippocampal-sparing, and minimal atrophy AD, had a specific signature of …

Background and Objectives White matter hyperintensities (WMH) correlate with Alzheimer
disease (AD) biomarkers cross-sectionally and modulate AD pathogenesis. Longitudinal …

Objective Neuropsychological test-specific neural substrates in subcortical vascular
cognitive impairment (SVCI) are expected to differ from those in Alzheimer's disease-related …

Objective: To investigate the relationship between cerebral amyloid angiopathy (CAA),
dementia, and cognitive function in an autopsy sample of 211 Japanese-American men from …

Introduction White matter lesions (WMLs), detected as hyperintensities on T2-weighted MRI,
represent small vessel disease in the brain and are considered a potential risk factor for …

Objective To determine if baseline measurements of cerebral atrophy and severity of white
matter hyperintensity (WMH) predict the rate of future cognitive decline in patients with …

Introduction Cognitive tests and nonamyloid imaging biomarkers do not consistently identify
preclinical AD. The objective of this study was to evaluate whether white matter …

Objective To apply an AT (Aβ/tau) classification system to subcortical vascular cognitive
impairment (SVCI) patients following recently developed biomarker-based criteria of …